Doctor profile · Federal record

Dr. Shari Mintz, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Denville, NJ

  • NPI 1730199696
  • Accepts Medicare
  • MIPS 85.4 / 100 · 2023
  • 27 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1 Indian RD, Suite 8
Denville, NJ 078342051
(973) 625-2121
fax (973) 625-8270

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
March 3, 2010
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State license (1)
New Jersey #25MA07699700

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1730199696. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
6,672
Distinct HCPCS
9
Medicare allowed
$313,830
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 4,800 50 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 714 369 $141
82962 Blood glucose (sugar) test performed by hand-held instrument 347 148 $3
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 184 73 $37
99215 Established patient office or other outpatient visit, 40-54 minutes 179 84 $194
99213 Established patient office or other outpatient visit, 20-29 minutes 176 142 $100
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 97 52 $85
99205 New patient office or other outpatient visit, 60-74 minutes 94 94 $239
76536 Ultrasound scan of head and neck soft tissue 81 81 $130

In context: peer comparison

Among 3 peers in Denville Endocrinology, Diabetes & Metabolism Physician, average services per provider: 767. This provider delivers 8.7× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$176
Transactions
3
Manufacturers
2
Payer (manufacturer) Industry Txns Amount
Amgen INC. 2 $113.32
Novo Nordisk INC 1 $62.48

By nature of payment

Food and Beverage
$176

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,999
Patients
792
Total drug cost
$1,412,067
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 729 184 $12,483
Metformin Hcl Generic 255 76 $3,409
Synthroid (Levothyroxine Sodium) Brand 239 58 $23,633
Trulicity (Dulaglutide) Brand 219 37 $326,256
Ozempic (Semaglutide) Brand 195 45 $252,429
Metformin Hcl ER (Metformin Hcl) Brand 186 58 $3,997
Glimepiride Generic 169 49 $2,333
Jardiance (Empagliflozin) Brand 152 35 $200,874
Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) Brand 151 38 $137,740
Atorvastatin Calcium Generic 150 45 $2,178

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Shari Mintz's medical specialty?
Dr. Shari Mintz practices Endocrinology, Diabetes & Metabolism Physician in Denville, NJ.
Where does Dr. Shari Mintz practice?
Dr. Shari Mintz practices at 1 Indian RD, Denville, NJ 078342051. Office phone: 9736252121.
What is Dr. Shari Mintz's NPI?
Dr. Shari Mintz's National Provider Identifier (NPI) is 1730199696, issued by NPPES.
Does Dr. Shari Mintz accept Medicare assignment?
Yes. Dr. Shari Mintz accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shari Mintz commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.